- Home
- CSX vs TNFA Comparison
CSX vs TNFA Comparison
Compare CSX & TNFA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CSX
- TNFA
- Stock Information
- Founded
- CSX 1978
- TNFA 2014
- Country
- CSX United States
- TNFA United States
- Employees
- CSX N/A
- TNFA N/A
- Industry
- CSX Railroads
- TNFA
- Sector
- CSX Industrials
- TNFA
- Exchange
- CSX Nasdaq
- TNFA NYSE
- Market Cap
- CSX N/A
- TNFA 760.1K
- IPO Year
- CSX N/A
- TNFA N/A
- Fundamental
- Price
- CSX $27.68
- TNFA $0.18
- Analyst Decision
- CSX Buy
- TNFA
- Analyst Count
- CSX 21
- TNFA 0
- Target Price
- CSX $33.86
- TNFA N/A
- AVG Volume (30 Days)
- CSX 18.4M
- TNFA 1.9M
- Earning Date
- CSX 04-16-2025
- TNFA 04-11-2025
- Dividend Yield
- CSX 1.88%
- TNFA N/A
- EPS Growth
- CSX N/A
- TNFA N/A
- EPS
- CSX 1.68
- TNFA N/A
- Revenue
- CSX $14,282,000,000.00
- TNFA N/A
- Revenue This Year
- CSX $1.19
- TNFA N/A
- Revenue Next Year
- CSX $4.87
- TNFA N/A
- P/E Ratio
- CSX $16.46
- TNFA N/A
- Revenue Growth
- CSX N/A
- TNFA N/A
- 52 Week Low
- CSX $26.22
- TNFA $0.17
- 52 Week High
- CSX $37.10
- TNFA $3.37
- Technical
- Relative Strength Index (RSI)
- CSX 40.45
- TNFA 24.71
- Support Level
- CSX $27.16
- TNFA $0.21
- Resistance Level
- CSX $28.78
- TNFA $0.29
- Average True Range (ATR)
- CSX 1.01
- TNFA 0.05
- MACD
- CSX 0.03
- TNFA -0.01
- Stochastic Oscillator
- CSX 41.24
- TNFA 3.69
About TNFA TNF PHARMACEUTICALS INC EFFEC
TNF Pharmaceuticals Inc is a clinical-stage pharmaceutical company committed to extending a healthy lifespan. The company is developing and commercializing two therapeutic platforms. MyMD-1 is a small molecule that regulates the immunometabolic system to treat autoimmune diseases, including multiple sclerosis, diabetes, rheumatoid arthritis, and inflammatory bowel disease. It is being developed to treat age-related illnesses such as frailty and sarcopenia. Supera-CBD is a synthetic derivative of CBD being developed to treat various conditions, including epilepsy, pain, and anxiety/depression, through its effects on the CB2 receptor, opioid receptors, and monoamine oxidase enzyme type B.